In vitro efficiency of vancomycin containing experimental drug delivery systems

Acta Microbiol Immunol Hung. 2013 Dec;60(4):461-8. doi: 10.1556/AMicr.60.2013.4.7.

Abstract

Biofilm-forming Staphylococcus epidermidis strains are common cause of the periprosthetic infection. The treatment of the periprosthetic infection is very problematic, so the prevention of these infections by an antibiotic containing prothesis could be an option for prevention.The purpose of the present study was to examine the in vitro effects of drug delivery systems (DDSs), namely Wax 1 and Wax 2 with different vancomycin content: 0.5, 1, 2 and 4 mg. In order to control the antibacterial activity of DDSs killing curve study was performed and in order to determine the antibiotic release and the antibiotic peak concentration from the DDSs biological assay was carried out.The time kill curve studies showed, that both DDSs with all vancomycin concentration decreased significantly the bacterial counts, however, Wax 2 with 4 mg vancomycin significantly decreased the bacterial count than all the other groups.The vancomycin release was the best with the highest peak concentration from DDSs with 4 mg vancomycin contain; it was significantly better than in the other groups, however, no significant difference was observed between Wax 1 and Wax 2 in this respect.These findings suggest that Wax 2 with 4 mg vancomycin content could be a potential agent for clinical use.

Keywords: drug delivery system; vancomycin.

MeSH terms

  • Anti-Bacterial Agents / administration & dosage*
  • Bacterial Load
  • Drug Delivery Systems*
  • Staphylococcus epidermidis / drug effects
  • Vancomycin / administration & dosage*

Substances

  • Anti-Bacterial Agents
  • Vancomycin